Zobrazeno 1 - 10 of 699 pro vyhledávání: '"Krause, BR"'
1
Akademický článek
ER-LD Membrane Contact Sites: A Budding Area in the Pathogen Survival Strategy.
Autor: Angara, Rajendra Kumar1 (AUTHOR), Sladek, Margaret F.1 (AUTHOR), Gilk, Stacey D.1 (AUTHOR) sgilk@unmc.edu
Publikováno v: Contact (25152564). 12/18/2024, p1-10. 10p.
Zobrazit plný text záznamu
2
Akademický článek
Effects of Statins on Skeletal Muscle Contractile Properties in Rats.
Autor: ÜNSAL, Cengiz1 cunsal@adu.edu.tr, YILDIRIM, Ece KOÇ1, AKKOÇ, Ayşe Nur2, ÜNSAL, Hümeyra1
Publikováno v: Kafkas Universitesi Veteriner Fakultesi Dergisi. Jul/Aug2024, Vol. 30 Issue 4, p473-479. 7p.
Zobrazit plný text záznamu
3
Akademický článek
High‐density lipoprotein in diabetes: Structural and functional relevance.
Autor: Lui, David Tak Wai1 (AUTHOR), Tan, Kathryn Choon Beng1 (AUTHOR) kcbtan@hku.hk
Publikováno v: Journal of Diabetes Investigation. Jul2024, Vol. 15 Issue 7, p805-816. 12p.
Zobrazit plný text záznamu
4
Akademický článek
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity.
Autor: Svecla, Monika1 (AUTHOR), Da Dalt, Lorenzo1 (AUTHOR), Moregola, Annalisa1 (AUTHOR), Nour, Jasmine1 (AUTHOR), Baragetti, Andrea1 (AUTHOR), Uboldi, Patrizia1 (AUTHOR), Donetti, Elena2 (AUTHOR), Arnaboldi, Lorenzo1 (AUTHOR), Beretta, Giangiacomo3 (AUTHOR), Bonacina, Fabrizia1 (AUTHOR), Norata, Giuseppe Danilo1 (AUTHOR) danilo.norata@unimi.it
Publikováno v: Cardiovascular Diabetology. 1/28/2024, Vol. 23 Issue 1, p1-17. 17p.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
Autor: Shamburek RD; Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA. Electronic address: bobs@mail.nih.gov., Bakker-Arkema R; AlphaCore Pharma, Ann Arbor, MI, USA., Auerbach BJ; AlphaCore Pharma, Ann Arbor, MI, USA., Krause BR; AlphaCore Pharma, Ann Arbor, MI, USA., Homan R; AlphaCore Pharma, Ann Arbor, MI, USA., Amar MJ; Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA., Freeman LA; Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA., Remaley AT; Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.
Publikováno v: Journal of clinical lipidology [J Clin Lipidol] 2016 Mar-Apr; Vol. 10 (2), pp. 356-67. Date of Electronic Publication: 2015 Dec 23.
Zobrazit plný text záznamu
10
Akademický článek
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
Autor: Shamburek RD; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.). bobs@mail.nih.gov., Bakker-Arkema R; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Shamburek AM; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Freeman LA; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Amar MJ; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Auerbach B; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Krause BR; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Homan R; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Adelman SJ; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Collins HL; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Sampson M; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Wolska A; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.)., Remaley AT; From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.).
Publikováno v: Circulation research [Circ Res] 2016 Jan 08; Vol. 118 (1), pp. 73-82. Date of Electronic Publication: 2015 Dec 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje